Timothy syndrome 1 (TS1) is a rare genetic disorder characterized by multisystem abnormalities including QT prolongation, congenital heart defects, facial dysmorphism, episodic hypoglycemia, and neurological symptoms. A morphological hallmark of TS1 is syndactyly, present in all cases. TS1 is caused by the canonical p.Gly406Arg mutation in the alternatively spliced exon 8A in the CACNA1C gene, encoding for the main cardiac L-type calcium channel. A variant case of TS1 is reported. The proband had intermittent fetal bradycardia with heart rate of 72 bpm. On the first day of life bradycardia due to 2:1 atrioventricular (AV) block and marked QTc prolongation of 600 ms was noted. On medical therapy with propranolol and mexiletine 1:1 AV conduction returned with QTc prolongation of 470-580 ms. The patient lacked other extracardiac manifestations, most importantly syndactyly, neurological complications or autism. On genetic analysis, the canonical TS1 causing mutation, p.Gly406Arg in exon 8A of the CACNA1C gene was detected. The CACNA1C p.Gly406Arg variant was not present in the parents, but was detected in different DNA samples of the index patient. Our case highlight further phenotypic variability in TS. Most importantly, it underlines that the lack of syndactyly does not exclude the presence of a TS1 genotype.
INTRODUCTION
Timothy syndrome (TS) is a very rare genetic disorder which is characterized by numerous multisystem abnormalities leading to clinically two distinct forms of the syndrome (reviewed in Liao and Soong [2010] ). Timothy syndrome 1 (TS1) is characterized by QT prolongation, congenital heart defects (including patent ductus arteriosus, patent foramen ovale, and ventricular septal defect), facial dysmorphisms (including a depressed nasal bridge, small upper jaw, low-set ears, or small and misplaced teeth), episodic hypoglycemia, and neurologic symptoms including developmental delays, autism, seizures, and intellectual disability [Splawski et al., 2004] . A morphological hallmark of TS1 is syndactyly, which is reported to be present in 100% of the cases (Table I) [Splawski et al., 2004; Lo-A-Njoe et al., 2005; Etheridge et al., 2011; Krause et al., 2011; An et al., 2013; Dufendach et al., 2013; Corona-Rivera et al., 2015; Erg€ ul et al., 2015] . Timothy syndrome 2 (TS2) patients have no syndactyly but carry the other multisystem manifestations of the disease [Splawski et al., 2005;  Fr€ ohler et al., 2014; Diep and Seaver, 2015; Hiippala et al., 2015; Philipp and Rodriguez, 2016] . Because of extreme QT prolongation, individuals with TS can experience ventricular tachycardia/ fibrillation (VT/VF) and cardiac arrest, and the overall complications of multisystem abnormalities often lead to early death. The predominant genetic cause of TS1, identified in 2004 [Splawski et al., 2004] , was a recurrent, canonical "de novo" heterozygous missense mutation, p.Gly406Arg, in the alternatively spliced exon 8A in the CACNA1C gene, encoding for the main cardiac L-type calcium channel, Ca v 1.2. In cases with TS2, an identical p.Gly406Arg and an additional p.Gly402Ser mutation was identified in exon 8 of the CACNA1C gene [Splawski et al., 2005] . Exons 8 and 8A of the CACNA1C gene undergo alternative splicing in a mutually exclusive manner, with exon 8 being the predominantly expressed isoform. Recently, some other mutations, all affecting the CACNA1C gene, were reported in TS patients [Gillis et al., 2012; Boczek et al., 2015; Wemh€ oner et al., 2015] .
Here, we report a variant case of Timothy syndrome, manifested as neonatal 2:1 AV block and marked QT prolongation. Genetic analysis revealed a CACNA1C gene exon 8A p.Gly406Arg mutation, thereby, defining the case as Timothy syndrome 1 on genetic grounds. However, the patient lacks many of the other hallmarks of TS1, most notably syndactyly, and also other major extracardiac manifestations.
PATIENT AND METHODS Clinical Report
The proband was born as a second child to a healthy 31-year-old woman and 31-year-old man, both of Caucasian descent. There was no report of consanguinity, and the family histories were noncontributory. Especially, family history was negative for premature sudden cardiac death, arrhythmic disorders, syndactyly, facial dysmorphism, or autism. The pregnancy was uncomplicated. Intermittent fetal bradycardia (heart rate of 72 bpm) was noted at 37 weeks gestation. The baby was born via normal uncomplicated vaginal delivery at 38 weeks gestation. Apgar scores were 9 and 10 at 1 and 5 min, respectively. The baby's birth weight was 2,950 g (18th centile), length was 54 cm (98th centile), and head circumference measured 34 cm (35th centile). On the second day of life cardiac evaluation revealed bradycardia due to 2:1 atrioventricular (AV) conduction and marked QTc-interval prolongation of 600 ms (Fig. 1, Panel A) . On medical therapy (propranolol and mexiletine) QTc duration stabilized in the range of 470-580 ms; 2:1 AV conduction resolved, and there was consistent 1:1 AV conduction with T-wave alternans (Fig. 1, Panel B) . Initial imaging with echocardiography demonstrated a patent foramen ovale, with a diameter of 2.5 mm with left-to-right shunt, and a mildly dilated right ventricle. The ductus arteriosus was closed and there were no signs of ventricular septal defect, cardiomyopathy or ventricular dysfunction. Laboratory findings did not reveal hypoglycemia or hypocalcaemia. The patient did not have facial dysmorphisms (hypertelorism, depressed nasal bridge, prominent forehead, etc.) and was not bald. He did not have joint hypermobility. Most importantly no syndactyly, either on the hands or on the Reported as exon 9, but based on direct sequence comparison it corresponds to exon 8A.
feet, were present (Fig. 1 , Panel C and D). No hypoplastic teeth and decay was noted. During his first 3 years of life he has made steady developmental progress. He sat unassisted at age 7.5 months, crawled at age 8 months, walked with support at age 8.5 months, and walked independently at age 12 months. First words were at age 14 months. At age 2 years an M-CHAT (Modified Checklist for Autism in Toddlers) test was done which did not indicate autism or autism spectrum disorder. He does not have frequent or serious infections. As the patient's father is a board certified cardiologist, he is under continuous bed-side ECG monitoring during nights with frequent traditional Holter monitoring performed in every 3-6 month. Only at one occasion a 2:1 AV conduction was detected for 12 hr, without symptoms, but no sustained or non-sustained ventricular tachyarrhythmias were ever encountered. At age 2 years he was hospitalized because of an episode of severe hypoglycemia (blood glucose level 1.4 mmol/L) associated with convulsions. As head trauma could not be excluded, a cranial CT was performed under general anesthesia. No VT or VF was observed under medication with propofol, midazolam, fentanyl, and muscle relaxants. The only observed rhythm disturbance was an intermittent 2:1 AV block which returned to normal conduction after the correction of serum glucose levels. The episode resolved without any further consequence. Glucose monitoring with tissue glucose sensor did not reveal any further episode of hypoglycemia in the subsequent days. At present, at age 3 years, his mental and physical development seems to be normal. He is in a good general health and attends kindergarten without assistance. He is able to express feelings, understands jokes, and sadness.
Molecular Genetic Analysis
The investigations were approved by the Institutional Ethics Committee of the University of Szeged, and conducted according to the Helsinki declaration. Family members and the patient's care-givers gave prior written informed consent to the molecular genetic analysis. Coding sequences and exon-intron boundaries of all 13 causative long QT genes were analyzed by next-generation sequencing using Agilent's SureSelect technology with custom-designed 120-mer RNA baits specific to target region (Agilent Technologies, Santa Clara, CA). Targeted resequencing was carried out on a SOLiD 5500xl System (Life Technologies, Grand Island, NY). Variants, identified by targeted resequencing, were validated by standard capillary sequencing using custom-designed primers. Exon 37 of ANK2 gene, exon 8A of CACNA1C gene, and exon 1 of KCNQ1 gene were direct-sequenced on a ABI Prism 310 Genetic Analyzer (Applied Biosystems by Life Technologies). Genetic mosaicism was assessed in the index patient and both parents using DNA extracted from buccal cells and from sperm, in case of father.
Mapping of the SOLiD reads were accomplished by Genomic Workbench ver 7.0.3 (CLC Bio, now part of Qiagen) using the human genome assembly hg19 as reference sequence. Variant calling and variant annotation were performed by the same software. The functional impact of amino acid changes caused by missense mutations was predicted by SIFT and PROVEAN programs. Nucleotide and amino acid changes are reported according to the Ensembl database (release: 85), based on reference sequences ENST00000155840.9 for KCNQ1, ENST00000399591.5 for CAC-NA1C, and ENST00000264366.10 for ANK2. 
RESULTS

Mutation Data
Three different heterozygous genetic variants in three genes have been detected using targeted resequencing by next-generation sequencing: p.Gly406Arg (c.1216G>A, rs79891110) in exon 8A of the CACNA1C gene (Fig. 2) ; p.Tyr94Cys (c.281A>G, rs781717051) in exon 1 of the KCNQ1 gene; and p.Ile3252Thr (c.9755T>C, rs36210417) in exon 37 of the ANK2 gene. All three variants were previously reported. The KCNQ1 p.Tyr94Cys variant was predicted to be deleterious by PRO-VEAN and to be tolerant by SIFT. The ANK2 p.Ile3252Thr variant was predicted to be neutral/tolerant by both prediction methods. The identified CACNA1C gene exon 8A p.Gly406Arg variant is the canonical Timothy syndrome 1 causing mutation. Although sequence homology is high between exons 8 and 8A of the CACNA1C gene, the presence of several "exon specific" nucleotides made possible to distinguish between the two (Fig. 2) . Sequence comparison with all available published sequences of CACNA1C exon 8 and 8A in previous reports proved that our patient indeed carried the p.Gly406Arg variant affecting exon 8A of the CACNA1C gene. The CACNA1C p.Gly406Arg variant was also present in the DNA sample of the index patient extracted from buccal, uroepithelial, and hair follicular cells. The height of the mutant nucleotide peak was similar in the different samples and were equal to the normal nucleotide peak (Fig. 2) .
Family Screening
First degree family members of the index patient (mother, father, and sister) underwent genetic screening for all three variants. The proband's father was proved to be carrier of the KCNQ1 p. Tyr94Cys variant, while mother and sister were non-carriers for both the KCNQ1 and ANK2 variants. Neither the parents nor the sister of the index patient carried the CACNA1C p.Gly406Arg variant (Fig. 2) , therefore, this variant must have arisen "de novo" (paternity was proven). The KCNQ1 p.Tyr94Cys variant-carrying father has no signs or symptoms of long QT syndrome and has a completely normal ECG and echocardiogram (data not shown), suggesting that the KCNQ1 p.Tyr94Cys variant has no major influence on the disease phenotype.
In order to assess whether the CACNA1C p.Gly406Arg mutation is indeed arisen "de novo" in the family, or one of the parents has mosaicism for the mutation, we performed genetic analysis of the DNA extracted from buccal cells (in case of both parents) and sperm (in case of father). The CACNA1C p.Gly406Arg variant was not present in any sample extracted from different tissues, therefore no proof for genetic mosaicism was found (data not shown).
DISCUSSION
Here we report a variant case of Timothy syndrome, caused by a TS1-specific CACNA1C exon 8A p.Gly406Arg mutation. The clinical phenotype was characterized by neonatal 2:1 AV block and marked QT prolongation. However, the patient lacked many of the other hallmarks of TS1, most notably syndactyly, and no other major extracardiac manifestations were present.
Syndactyly is reported in 100% of patients with CACNA1C exon 8A p.Gly406Arg mutation (Table I) . Moreover, syndactyly was also present in patients proved to be somatic or germline mosaic carriers of the mutation [Etheridge et al., 2011; Dufendach et al., 2013] . In one of these cases the direct presence of the CACNA1C exon 8A p.Gly406Arg mutation was demonstrated in left/right arm skin biopsy samples with an estimated percent mosaicism of $6.5% [Dufendach et al., 2013] . As Ca v 1.2 was highly expressed in apical ectodermal ridge cells of developing digits, syndactyly is thought to be caused in TS by Ca 2þ -induced cell death in the apical ectodermal ridge [Splawski et al., 2004] .
FIG. 2.
Sequence analysis of exon 8A of the CACNA1C gene illustrating the c.1216G>A mutation. The mutation changes the GGA triplet at codon 406, encoding for glycine, to AGA, encoding for arginine (p.Gly406Arg). Sequencing result is shown from DNA isolated from blood (patient, father, mother) and from buccal cells (patient). Testing of parents suggested that the mutation is "de novo." Nucleotides framed in red are unique for exon 8A when compared to homologous exon 8.
There are several possible explanations for the lack of syndactyly and major extracardiac manifestations in our case. One of the possible reasons for the variant phenotype might be the variable expression of exons 8A and 8 of the CACNA1C gene in different tissues. Exons 8 or 8A are mutually exclusive exons, which encode the transmembrane segment 6 of domain I (DI/S6). Exon 8A, although, expressed in multiple adult and fetal tissues, including heart, brain, gastrointestinal system, lungs, immune system, smooth muscle, and testis, represents the less dominant cardiac and brain isoform of CACNA1C, as its relative expression was consistently shown to be significantly much lower than exon 8 in heart and brain (23% vs. 77%) [Splawski et al., 2004] . The mutant exon 8A isoform might be present in even less amount in non-affected tissues and the milder dysfunction in the Ca v 1.2 ion channel could possibly be compensated by the non-mutant exon 8 isoform or by other mechanisms. In addition, the role of modifier genes, known to alter the disease phenotype in many diseases [Vo and McNally, 2015; Arning, 2016] , cannot be ruled out either.
Another explanation for the variant phenotype is the possible presence of somatic mosaicism in our patient, as reports on mosaic patients with TS1 describe a partial phenotype of the disease, similar to ours [Etheridge et al., 2011; Dufendach et al., 2013] . The possible presence of somatic mosaicism was also reported with regard to TS2 [Splawski et al., 2005; Hiippala et al., 2015] . According to this scenario, the mutant Ca v 1.2 channel must be absent from unaffected organs (limbs, brain) and might be present in low levels in probably affected organs (heart, pancreas) in our patient. However, as we had four sources of tissue (lymphocytes, buccal cells, uroepithelial cells, hair follicles), and all were shown to harbor the mutation, direct evidence for the above explanation is lacking. Despite of this, mosaicism cannot be ruled out completely, as samples were not available from tissues characteristically affected in TS (i.e., brain and digits).
In conclusion, we described a Timothy syndrome 1 genotype without syndactyly and major extracardiac manifestations. The case highlight further phenotypic variability in Timothy syndrome. Most importantly, it underlines that the lack of syndactyly doesn't exclude the presence of Timothy syndrome 1 genotype.
